The Career Success of Dr. Scott M. Rocklage

Currently based in Boston, Scott M Rocklage is the managing partner of 5AM Ventures, a position he has held since 2004. Before that, he was a venture partner in 2003 when he joined the company.

Mr. Scott Rocklage has over 30 years of healthcare management experience with strategic leadership duties that led to FDA approval of omniscan, teslascan, and cubin which are three new drug applications in the US.

Scott once served as the CEO of Cubist Pharmaceuticals and also as the President and CEO of Nycomed Salutar, where he has also worked as the Board Chairman Of Rennovia, Kinestral, and Cidara. He is also a board member of Epirus and Pulmitrix.

Apart from the above, Dr Scott was also formerly the executive chairman of Ilypsa, Mikanaa, and Semprus. He got his BS in Chemistry from the University of California Berkeley and has a Ph.D. in the same field from MIT where he conducted research in the laboratory of Richard R Schrock. Scott is an inventor or co-inventor of more than thirty US patents and has over one hundred peer reviewed publications and Scott’s lacrosse camp.

In an interview by Idea Mensch in April 4th, 2017, Rocklage stated that 5AM Ventures is a life science and the company considers early stage of life. He also said he does not have a typical routine day because some days are for studying new areas of life science, some are for working with the portfolio company management team, and others are for attending Board meetings. Despite not having a particular routine, Rocklage is more organized when it comes to managing time and prioritizing, and says that if asked to start again, he will focus more on people just as he has done before.

Rocklage also works with entrepreneurs who are scientists, physicians, or business executives to aid them shape their ideas into potential medicines to treat unmet medical requirements. He also stated that explosive growth in being able to target specific mutations or genotypes to treat cancer in unique ways has led to extending and saving lives and plans with his entrepreneurs to develop an improvement in the future and what Scott knows.

Scott encourages entrepreneurs to take calculated risks. They should stay true to their business and says that not staying too far from their strengths is very important in trial times.

More visit: